Litcius/Paper detail

Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study

Lei Zhang, Junhui Sun, Jiansong Ji, Bin‐Yan Zhong, Guan‐Hui Zhou, Jingjing Song, Zhong-Heng Hou, Peng Huang, Shen Zhang, Zhi Li, Xiaoli Zhu, Cai‐Fang Ni

2020American Journal of Roentgenology36 citationsDOI

Abstract

Greater caution and closer follow-up are warranted for patients who undergo DEB-TACE for unresectable HCC than for those who undergo cTACE.

Topics & Concepts

MedicineHepatocellular carcinomaGastroenterologyInternal medicineBile ductRadiologyAdverse effectLiver cancerAbdominal painHepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation
Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study | Litcius